Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics
Clinica Chimica Acta · 2026
DOI: 10.1016/j.cca.2025.120786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinica Chimica Acta, 2026. Verfasst von Sadegh Zarei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Cent…. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Rafsanjan University of Medical Sciences.
Abstract (Originalsprache)
Kidney cancer, particularly clear cell renal cell carcinoma (ccRCC), presents a significant clinical burden due to late-stage detection and limited effectiveness of current diagnostic modalities. Minimally invasive strategies, such as liquid biopsy, have emerged as promising alternatives, with microRNAs (miRNAs) gaining attention as stable, disease-specific biomarkers detectable in biofluids. miRNAs function as oncogenes or tumor suppressors, offering advantages over conventional protein biomarkers in early cancer detection and prognostic assessment. Electrochemical biosensors provide a highly sensitive, rapid, and cost-effective platform for miRNA detection, enabling potential point-of-care applications. Recent advances include the integration of nanomaterials, enzymatic and isothermal amplification methods, and CRISPR-Cas systems to enhance specificity and signal sensitivity. Prototype sensors targeting RCC-relevant miRNAs, multiplexed detection for biomarker panels, and smartphone-compatible platforms demonstrate the feasibility of translating these technologies into clinical practice. Despite challenges in assay standardization, pre-analytical variability, and regulatory pathways, electrochemical miRNA biosensors hold transformative potential for non-invasive RCC diagnostics, treatment monitoring, and precision oncology. Continued innovation and clinical validation may establish these platforms as integral tools for personalized patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University…
- Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Health Education and Health Promotion, Faculty of Public Health, Iran University of Medical Sciences, Tehran, Iran.
- Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran. Electronic address: hosseiniara7@gmail.com.
Förderung
- Rafsanjan University of Medical Sciences
Zitieren
APA
Zarei, S., Hosseiniara, S. M., Zijoud, S. S. H., & Hosseiniara, R. (2026). Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2025.120786
Vancouver
Zarei S, Hosseiniara SM, Zijoud SSH, Hosseiniara R. Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics. Clinica Chimica Acta. 2026. doi:10.1016/j.cca.2025.120786
BibTeX
@article{Zarei2026,
author = {Zarei, Sadegh and Hosseiniara, Seyed Morteza and Zijoud, Solmaz Sadat Hosseini and Hosseiniara, Reza},
title = {Electrochemical MicroRNA biosensors for kidney Cancer: From biomarker discovery to point-of-care diagnostics},
journal = {Clinica Chimica Acta},
year = {2026},
doi = {10.1016/j.cca.2025.120786}
}
EUVIMED